Laurie Elit

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Amit M. Oza, Laurie Elit, Ming‐Sound Tsao et al. · Journal of Clinical Oncology · 2011 · 338 citations · Full text

Medicine, Oncology, Pharmacology +15

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer

Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit et al. · Current Oncology · 2007 · 226 citations · Full text

Medicine, Gynecology, Oncology +14

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation

Amy Finch, Kelly Metcalfe, Jaclyn Chiang et al. · Gynecologic Oncology · 2011 · 199 citations

Medicine, Gynecology, Surgery +17